CymaBay Therapeutics is defunct.

Acquired by Gilead, Mar 2024, $4.3B


----------------------------------------
If you believe any of this information is incorrect, please let us know.

If you would like in depth information on the active companies in our directory, please check out our data purchase page to learn more about the data fields we have and how the purchasing process works.

We are always happy to answer any questions so feel free to contact us through the contact form.